Cefiderocol
Product Specifications
UNSPSC Description
Cefiderocol (S-649266) is a siderophore cephalosporin which has a potent activity against a broad range of aerobic Gram-negative bacterial species with MIC50s of 2 μg/mL or less.
Target Antigen
Antibiotic; Bacterial
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-immunoregulation
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/cefiderocol.html
Solubility
DMSO : 100 mg/mL (ultrasonic)|H2O : 1.06 mg/mL (ultrasonic)
Smiles
O=C(C(N12)=C(C[N+]3(CCNC(C4=CC=C(O)C(O)=C4Cl)=O)CCCC3)CS[C@]2([H])[C@H](NC(/C(C5=CSC(N)=N5)=N\OC(C)(C(O)=O)C)=O)C1=O)[O-]
Molecular Weight
752.21
References & Citations
[1]Ito A, et al. In Vitro Antibacterial Properties of Cefiderocol, a Novel Siderophore Cephalosporin, against Gram-Negative Bacteria. Antimicrob Agents Chemother. 2017 Dec 21;62(1).
Shipping Conditions
Blue Ice
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-17628/Cefiderocol-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-17628/Cefiderocol-SDS-MedChemExpress.pdf
Clinical Information
Launched
CAS Number
1225208-94-5
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1218770-01 0.02 mg (E-Coli)
Recombinant Bauhinia bauhinioides Kunitz-type serine protease inhibitor BbKI
Ask
View Details 
MBS1218770-02 0.1 mg (E-Coli)
Recombinant Bauhinia bauhinioides Kunitz-type serine protease inhibitor BbKI
Ask
View Details MBS1218770-03 0.02 mg (Yeast)
Recombinant Bauhinia bauhinioides Kunitz-type serine protease inhibitor BbKI
Ask
View Details MBS1218770-04 0.1 mg (Yeast)
Recombinant Bauhinia bauhinioides Kunitz-type serine protease inhibitor BbKI
Ask
View Details